nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—type 2 diabetes mellitus	0.32	1	CbGaD
Dantrolene—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0511	0.152	CbGbCtD
Dantrolene—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0456	0.136	CbGbCtD
Dantrolene—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0417	0.124	CbGbCtD
Dantrolene—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0364	0.109	CbGbCtD
Dantrolene—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.033	0.0982	CbGbCtD
Dantrolene—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.025	0.0744	CbGbCtD
Dantrolene—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0239	0.0713	CbGbCtD
Dantrolene—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0239	0.0713	CbGbCtD
Dantrolene—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0226	0.0675	CbGbCtD
Dantrolene—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0169	0.0503	CbGbCtD
Dantrolene—CYP3A4—Losartan—type 2 diabetes mellitus	0.0154	0.046	CbGbCtD
Dantrolene—RYR3—Ion channel transport—ATP2A3—type 2 diabetes mellitus	0.00144	0.0121	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GRK5—type 2 diabetes mellitus	0.00142	0.0119	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—GRK5—type 2 diabetes mellitus	0.00137	0.0116	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—PLN—type 2 diabetes mellitus	0.00136	0.0114	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CRHR1—type 2 diabetes mellitus	0.00135	0.0113	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ATF3—type 2 diabetes mellitus	0.00114	0.00956	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ATP2A3—type 2 diabetes mellitus	0.00113	0.00953	CbGpPWpGaD
Dantrolene—RYR1—Stimuli-sensing channels—TRPC6—type 2 diabetes mellitus	0.00113	0.00953	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—LPL—type 2 diabetes mellitus	0.00112	0.00942	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ATP2A2—type 2 diabetes mellitus	0.0011	0.00929	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ATP2A3—type 2 diabetes mellitus	0.0011	0.00924	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00109	0.00917	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ATP2A2—type 2 diabetes mellitus	0.00107	0.009	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADRB3—type 2 diabetes mellitus	0.00106	0.00893	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—ATP2A3—type 2 diabetes mellitus	0.00106	0.00892	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.00103	0.00869	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—FAS—type 2 diabetes mellitus	0.00102	0.0086	CbGpPWpGaD
Dantrolene—RYR3—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.001	0.00843	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CRHR1—type 2 diabetes mellitus	0.000992	0.00835	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CALM1—type 2 diabetes mellitus	0.000941	0.00792	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—APOE—type 2 diabetes mellitus	0.000937	0.00789	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CALCA—type 2 diabetes mellitus	0.000898	0.00756	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NOS1—type 2 diabetes mellitus	0.000854	0.0072	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ATF3—type 2 diabetes mellitus	0.000837	0.00705	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ATP2A2—type 2 diabetes mellitus	0.000813	0.00685	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000802	0.00676	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GJA1—type 2 diabetes mellitus	0.000791	0.00666	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ATP2A2—type 2 diabetes mellitus	0.000788	0.00664	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP8—type 2 diabetes mellitus	0.000788	0.00664	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—GJA1—type 2 diabetes mellitus	0.000766	0.00645	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000761	0.00641	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—GNB3—type 2 diabetes mellitus	0.000739	0.00623	CbGpPWpGaD
Dantrolene—RYR1—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000738	0.00622	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000726	0.00612	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—GNB3—type 2 diabetes mellitus	0.000716	0.00603	CbGpPWpGaD
Dantrolene—CYP3A4—Codeine and Morphine Metabolism—ABCC2—type 2 diabetes mellitus	0.000706	0.00594	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000701	0.00591	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000701	0.00591	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CALCA—type 2 diabetes mellitus	0.000662	0.00557	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—ADCY5—type 2 diabetes mellitus	0.000659	0.00555	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000642	0.0054	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—ADCY5—type 2 diabetes mellitus	0.000638	0.00538	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NOS1—type 2 diabetes mellitus	0.00063	0.00531	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—CASP3—type 2 diabetes mellitus	0.000596	0.00502	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GJA1—type 2 diabetes mellitus	0.000583	0.00491	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000572	0.00482	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000572	0.00482	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—CALM1—type 2 diabetes mellitus	0.000566	0.00477	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—GJA1—type 2 diabetes mellitus	0.000565	0.00476	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.00055	0.00464	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.00055	0.00464	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—CALM1—type 2 diabetes mellitus	0.000549	0.00462	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—GNB3—type 2 diabetes mellitus	0.000545	0.00459	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000541	0.00455	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000535	0.00451	CbGpPWpGaD
Dantrolene—RYR3—Calcium Regulation in the Cardiac Cell—PRKCB—type 2 diabetes mellitus	0.000532	0.00448	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—GNB3—type 2 diabetes mellitus	0.000528	0.00445	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—type 2 diabetes mellitus	0.000528	0.00445	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000517	0.00436	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000517	0.00436	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—PRKCB—type 2 diabetes mellitus	0.000516	0.00434	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.0005	0.00421	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—ADCY5—type 2 diabetes mellitus	0.000486	0.00409	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000473	0.00398	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—ADCY5—type 2 diabetes mellitus	0.000471	0.00396	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000468	0.00394	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000452	0.00381	CbGpPWpGaD
Dantrolene—CYP3A4—Irinotecan Pathway—ABCC2—type 2 diabetes mellitus	0.000451	0.0038	CbGpPWpGaD
Dantrolene—CYP3A4—Liver X Receptor Pathway—SREBF1—type 2 diabetes mellitus	0.000439	0.0037	CbGpPWpGaD
Dantrolene—RYR3—Alzheimers Disease—TNF—type 2 diabetes mellitus	0.000434	0.00365	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000433	0.00365	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000422	0.00355	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000422	0.00355	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—CALM1—type 2 diabetes mellitus	0.000417	0.00352	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NOS3—type 2 diabetes mellitus	0.00041	0.00345	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000406	0.00342	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000406	0.00342	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.000405	0.00341	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—CALM1—type 2 diabetes mellitus	0.000404	0.00341	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000399	0.00336	CbGpPWpGaD
Dantrolene—RYR1—Calcium Regulation in the Cardiac Cell—PRKCB—type 2 diabetes mellitus	0.000392	0.0033	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.000392	0.0033	CbGpPWpGaD
Dantrolene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000386	0.00325	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—PRKCB—type 2 diabetes mellitus	0.00038	0.0032	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000376	0.00317	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000368	0.0031	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000359	0.00302	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000359	0.00302	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.00035	0.00295	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.00035	0.00295	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000348	0.00293	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000346	0.00292	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000345	0.00291	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000333	0.00281	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—NFKB1—type 2 diabetes mellitus	0.000325	0.00274	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000319	0.00269	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000305	0.00257	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NOS3—type 2 diabetes mellitus	0.000302	0.00254	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000291	0.00245	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.00029	0.00245	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000279	0.00235	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000277	0.00234	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	0.000276	0.00232	CbGpPWpGaD
Dantrolene—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	0.000272	0.00229	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000265	0.00223	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000265	0.00223	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000258	0.00218	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000257	0.00216	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000255	0.00215	CbGpPWpGaD
Dantrolene—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	0.000248	0.00209	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000241	0.00203	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—NFKB1—type 2 diabetes mellitus	0.00024	0.00202	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.00024	0.00202	CbGpPWpGaD
Dantrolene—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	0.000237	0.002	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000237	0.002	CbGpPWpGaD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	0.000233	0.00196	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	0.00023	0.00194	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000229	0.00193	CbGpPWpGaD
Dantrolene—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	0.000228	0.00192	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000225	0.0019	CbGpPWpGaD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	0.000222	0.00187	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	0.000222	0.00187	CbGpPWpGaD
Dantrolene—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	0.000219	0.00185	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000215	0.00181	CbGpPWpGaD
Dantrolene—RYR3—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000215	0.00181	CbGpPWpGaD
Dantrolene—RYR1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000206	0.00173	CbGpPWpGaD
Dantrolene—RYR3—Myometrial Relaxation and Contraction Pathways—IL6—type 2 diabetes mellitus	0.000204	0.00172	CbGpPWpGaD
Dantrolene—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000203	0.000898	CcSEcCtD
Dantrolene—Rash—Glipizide—type 2 diabetes mellitus	0.000202	0.000894	CcSEcCtD
Dantrolene—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000202	0.000893	CcSEcCtD
Dantrolene—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000202	0.000893	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000202	0.000893	CcSEcCtD
Dantrolene—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000202	0.000892	CcSEcCtD
Dantrolene—Erythema—Losartan—type 2 diabetes mellitus	0.000202	0.000892	CcSEcCtD
Dantrolene—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000201	0.00089	CcSEcCtD
Dantrolene—Headache—Glipizide—type 2 diabetes mellitus	0.000201	0.000888	CcSEcCtD
Dantrolene—Insomnia—Gliclazide—type 2 diabetes mellitus	0.0002	0.000886	CcSEcCtD
Dantrolene—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000199	0.000881	CcSEcCtD
Dantrolene—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000199	0.00088	CcSEcCtD
Dantrolene—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000199	0.000879	CcSEcCtD
Dantrolene—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000198	0.000876	CcSEcCtD
Dantrolene—Tension—Losartan—type 2 diabetes mellitus	0.000198	0.000875	CcSEcCtD
Dantrolene—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000198	0.000875	CcSEcCtD
Dantrolene—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000197	0.000874	CcSEcCtD
Dantrolene—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000197	0.000872	CcSEcCtD
Dantrolene—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000197	0.000871	CcSEcCtD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	0.000196	0.00165	CbGpPWpGaD
Dantrolene—Hypertension—Metformin—type 2 diabetes mellitus	0.000196	0.000867	CcSEcCtD
Dantrolene—Urticaria—Glyburide—type 2 diabetes mellitus	0.000196	0.000867	CcSEcCtD
Dantrolene—Nervousness—Losartan—type 2 diabetes mellitus	0.000196	0.000867	CcSEcCtD
Dantrolene—Back pain—Losartan—type 2 diabetes mellitus	0.000195	0.000863	CcSEcCtD
Dantrolene—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000195	0.000863	CcSEcCtD
Dantrolene—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000195	0.000863	CcSEcCtD
Dantrolene—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000194	0.00086	CcSEcCtD
Dantrolene—Anorexia—Valsartan—type 2 diabetes mellitus	0.000194	0.000858	CcSEcCtD
Dantrolene—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000194	0.000857	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000194	0.00163	CbGpPWpGaD
Dantrolene—Myalgia—Metformin—type 2 diabetes mellitus	0.000193	0.000855	CcSEcCtD
Dantrolene—Malaise—Irbesartan—type 2 diabetes mellitus	0.000193	0.000855	CcSEcCtD
Dantrolene—Headache—Pioglitazone—type 2 diabetes mellitus	0.000192	0.000851	CcSEcCtD
Dantrolene—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000192	0.000849	CcSEcCtD
Dantrolene—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000191	0.000847	CcSEcCtD
Dantrolene—Discomfort—Metformin—type 2 diabetes mellitus	0.000191	0.000845	CcSEcCtD
Dantrolene—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000191	0.000845	CcSEcCtD
Dantrolene—Nausea—Glipizide—type 2 diabetes mellitus	0.00019	0.000842	CcSEcCtD
Dantrolene—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00019	0.000841	CcSEcCtD
Dantrolene—Vision blurred—Losartan—type 2 diabetes mellitus	0.00019	0.000841	CcSEcCtD
Dantrolene—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	0.00019	0.0016	CbGpPWpGaD
Dantrolene—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00019	0.000839	CcSEcCtD
Dantrolene—Constipation—Gliclazide—type 2 diabetes mellitus	0.000189	0.000838	CcSEcCtD
Dantrolene—Pain—Gliclazide—type 2 diabetes mellitus	0.000189	0.000838	CcSEcCtD
Dantrolene—Rash—Glimepiride—type 2 diabetes mellitus	0.000189	0.000834	CcSEcCtD
Dantrolene—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000188	0.000834	CcSEcCtD
Dantrolene—Rash—Sitagliptin—type 2 diabetes mellitus	0.000188	0.000832	CcSEcCtD
Dantrolene—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000188	0.000831	CcSEcCtD
Dantrolene—Headache—Glimepiride—type 2 diabetes mellitus	0.000187	0.000829	CcSEcCtD
Dantrolene—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000187	0.000828	CcSEcCtD
Dantrolene—Headache—Sitagliptin—type 2 diabetes mellitus	0.000187	0.000826	CcSEcCtD
Dantrolene—Anaemia—Losartan—type 2 diabetes mellitus	0.000186	0.000825	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000185	0.00082	CcSEcCtD
Dantrolene—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000185	0.000818	CcSEcCtD
Dantrolene—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000185	0.000817	CcSEcCtD
Dantrolene—Flushing—Ramipril—type 2 diabetes mellitus	0.000184	0.000816	CcSEcCtD
Dantrolene—Insomnia—Valsartan—type 2 diabetes mellitus	0.000184	0.000814	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000183	0.000811	CcSEcCtD
Dantrolene—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000183	0.000808	CcSEcCtD
Dantrolene—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000182	0.000807	CcSEcCtD
Dantrolene—Insomnia—Orlistat—type 2 diabetes mellitus	0.000182	0.000805	CcSEcCtD
Dantrolene—Malaise—Losartan—type 2 diabetes mellitus	0.000182	0.000805	CcSEcCtD
Dantrolene—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000182	0.000804	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000182	0.00153	CbGpPWpGaD
Dantrolene—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000181	0.000803	CcSEcCtD
Dantrolene—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000181	0.000801	CcSEcCtD
Dantrolene—Somnolence—Valsartan—type 2 diabetes mellitus	0.000181	0.0008	CcSEcCtD
Dantrolene—Leukopenia—Losartan—type 2 diabetes mellitus	0.00018	0.000799	CcSEcCtD
Dantrolene—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00018	0.000797	CcSEcCtD
Dantrolene—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000179	0.000793	CcSEcCtD
Dantrolene—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000179	0.000793	CcSEcCtD
Dantrolene—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000178	0.000789	CcSEcCtD
Dantrolene—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000178	0.000789	CcSEcCtD
Dantrolene—Nausea—Glimepiride—type 2 diabetes mellitus	0.000178	0.000786	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000177	0.00149	CbGpPWpGaD
Dantrolene—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000177	0.000784	CcSEcCtD
Dantrolene—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000177	0.000783	CcSEcCtD
Dantrolene—Asthenia—Glyburide—type 2 diabetes mellitus	0.000177	0.000783	CcSEcCtD
Dantrolene—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000177	0.000783	CcSEcCtD
Dantrolene—Anorexia—Metformin—type 2 diabetes mellitus	0.000177	0.000782	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000177	0.00149	CbGpPWpGaD
Dantrolene—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000176	0.000778	CcSEcCtD
Dantrolene—Fatigue—Valsartan—type 2 diabetes mellitus	0.000175	0.000776	CcSEcCtD
Dantrolene—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000175	0.000775	CcSEcCtD
Dantrolene—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000175	0.000775	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000175	0.00147	CbGpPWpGaD
Dantrolene—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000175	0.000774	CcSEcCtD
Dantrolene—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000175	0.000773	CcSEcCtD
Dantrolene—Pruritus—Glyburide—type 2 diabetes mellitus	0.000175	0.000772	CcSEcCtD
Dantrolene—Constipation—Valsartan—type 2 diabetes mellitus	0.000174	0.00077	CcSEcCtD
Dantrolene—Fatigue—Orlistat—type 2 diabetes mellitus	0.000173	0.000767	CcSEcCtD
Dantrolene—Erythema—Ramipril—type 2 diabetes mellitus	0.000173	0.000765	CcSEcCtD
Dantrolene—Pain—Orlistat—type 2 diabetes mellitus	0.000172	0.000761	CcSEcCtD
Dantrolene—Myalgia—Losartan—type 2 diabetes mellitus	0.000172	0.00076	CcSEcCtD
Dantrolene—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000172	0.000759	CcSEcCtD
Dantrolene—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000171	0.000758	CcSEcCtD
Dantrolene—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000171	0.000755	CcSEcCtD
Dantrolene—Rash—Bromocriptine—type 2 diabetes mellitus	0.00017	0.000753	CcSEcCtD
Dantrolene—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00017	0.000752	CcSEcCtD
Dantrolene—Tension—Ramipril—type 2 diabetes mellitus	0.00017	0.000751	CcSEcCtD
Dantrolene—Discomfort—Losartan—type 2 diabetes mellitus	0.00017	0.00075	CcSEcCtD
Dantrolene—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000169	0.000749	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000169	0.00142	CbGpPWpGaD
Dantrolene—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000169	0.000748	CcSEcCtD
Dantrolene—Headache—Bromocriptine—type 2 diabetes mellitus	0.000169	0.000748	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000169	0.000747	CcSEcCtD
Dantrolene—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000169	0.000747	CcSEcCtD
Dantrolene—Nervousness—Ramipril—type 2 diabetes mellitus	0.000168	0.000743	CcSEcCtD
Dantrolene—Dry mouth—Losartan—type 2 diabetes mellitus	0.000168	0.000743	CcSEcCtD
Dantrolene—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000167	0.000738	CcSEcCtD
Dantrolene—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000166	0.000736	CcSEcCtD
Dantrolene—Confusional state—Losartan—type 2 diabetes mellitus	0.000166	0.000734	CcSEcCtD
Dantrolene—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000166	0.000733	CcSEcCtD
Dantrolene—Somnolence—Metformin—type 2 diabetes mellitus	0.000165	0.000729	CcSEcCtD
Dantrolene—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000165	0.000728	CcSEcCtD
Dantrolene—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000164	0.000727	CcSEcCtD
Dantrolene—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000163	0.000722	CcSEcCtD
Dantrolene—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000163	0.000722	CcSEcCtD
Dantrolene—Urticaria—Valsartan—type 2 diabetes mellitus	0.000162	0.000715	CcSEcCtD
Dantrolene—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000161	0.000713	CcSEcCtD
Dantrolene—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000161	0.000713	CcSEcCtD
Dantrolene—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000161	0.000712	CcSEcCtD
Dantrolene—Tachycardia—Losartan—type 2 diabetes mellitus	0.000161	0.000711	CcSEcCtD
Dantrolene—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.00016	0.00071	CcSEcCtD
Dantrolene—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00016	0.000709	CcSEcCtD
Dantrolene—Fatigue—Metformin—type 2 diabetes mellitus	0.00016	0.000707	CcSEcCtD
Dantrolene—Urticaria—Orlistat—type 2 diabetes mellitus	0.00016	0.000707	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000159	0.000705	CcSEcCtD
Dantrolene—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000159	0.000704	CcSEcCtD
Dantrolene—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000159	0.000703	CcSEcCtD
Dantrolene—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000159	0.000703	CcSEcCtD
Dantrolene—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000159	0.000703	CcSEcCtD
Dantrolene—Constipation—Metformin—type 2 diabetes mellitus	0.000158	0.000701	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000158	0.00133	CbGpPWpGaD
Dantrolene—Anorexia—Losartan—type 2 diabetes mellitus	0.000157	0.000694	CcSEcCtD
Dantrolene—Vomiting—Glyburide—type 2 diabetes mellitus	0.000157	0.000694	CcSEcCtD
Dantrolene—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000157	0.000693	CcSEcCtD
Dantrolene—Malaise—Ramipril—type 2 diabetes mellitus	0.000156	0.00069	CcSEcCtD
Dantrolene—Rash—Glyburide—type 2 diabetes mellitus	0.000156	0.000688	CcSEcCtD
Dantrolene—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000155	0.000688	CcSEcCtD
Dantrolene—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000155	0.000687	CcSEcCtD
Dantrolene—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000155	0.000685	CcSEcCtD
Dantrolene—Headache—Glyburide—type 2 diabetes mellitus	0.000155	0.000684	CcSEcCtD
Dantrolene—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000154	0.000681	CcSEcCtD
Dantrolene—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	0.000153	0.00129	CbGpPWpGaD
Dantrolene—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000153	0.000676	CcSEcCtD
Dantrolene—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000152	0.000673	CcSEcCtD
Dantrolene—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000152	0.00067	CcSEcCtD
Dantrolene—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000152	0.00067	CcSEcCtD
Dantrolene—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000151	0.000667	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	0.000151	0.00127	CbGpPWpGaD
Dantrolene—RYR1—Myometrial Relaxation and Contraction Pathways—IL6—type 2 diabetes mellitus	0.00015	0.00127	CbGpPWpGaD
Dantrolene—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00015	0.000663	CcSEcCtD
Dantrolene—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00015	0.000663	CcSEcCtD
Dantrolene—Convulsion—Ramipril—type 2 diabetes mellitus	0.00015	0.000663	CcSEcCtD
Dantrolene—Pain—Irbesartan—type 2 diabetes mellitus	0.00015	0.000662	CcSEcCtD
Dantrolene—Constipation—Irbesartan—type 2 diabetes mellitus	0.00015	0.000662	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	0.000149	0.00126	CbGpPWpGaD
Dantrolene—Insomnia—Losartan—type 2 diabetes mellitus	0.000149	0.000659	CcSEcCtD
Dantrolene—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000148	0.000655	CcSEcCtD
Dantrolene—Urticaria—Metformin—type 2 diabetes mellitus	0.000147	0.000651	CcSEcCtD
Dantrolene—Myalgia—Ramipril—type 2 diabetes mellitus	0.000147	0.000651	CcSEcCtD
Dantrolene—Nausea—Glyburide—type 2 diabetes mellitus	0.000147	0.000648	CcSEcCtD
Dantrolene—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000146	0.000648	CcSEcCtD
Dantrolene—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000146	0.000648	CcSEcCtD
Dantrolene—Somnolence—Losartan—type 2 diabetes mellitus	0.000146	0.000647	CcSEcCtD
Dantrolene—Asthenia—Valsartan—type 2 diabetes mellitus	0.000146	0.000646	CcSEcCtD
Dantrolene—Discomfort—Ramipril—type 2 diabetes mellitus	0.000145	0.000643	CcSEcCtD
Dantrolene—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000145	0.000641	CcSEcCtD
Dantrolene—Asthenia—Orlistat—type 2 diabetes mellitus	0.000144	0.000638	CcSEcCtD
Dantrolene—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000144	0.000638	CcSEcCtD
Dantrolene—Pruritus—Valsartan—type 2 diabetes mellitus	0.000144	0.000637	CcSEcCtD
Dantrolene—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000144	0.000637	CcSEcCtD
Dantrolene—RYR3—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000144	0.00121	CbGpPWpGaD
Dantrolene—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000143	0.000633	CcSEcCtD
Dantrolene—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000143	0.000633	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000143	0.0012	CbGpPWpGaD
Dantrolene—Confusional state—Ramipril—type 2 diabetes mellitus	0.000142	0.00063	CcSEcCtD
Dantrolene—Pruritus—Orlistat—type 2 diabetes mellitus	0.000142	0.000629	CcSEcCtD
Dantrolene—Fatigue—Losartan—type 2 diabetes mellitus	0.000142	0.000628	CcSEcCtD
Dantrolene—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000141	0.000624	CcSEcCtD
Dantrolene—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000141	0.000623	CcSEcCtD
Dantrolene—Constipation—Losartan—type 2 diabetes mellitus	0.000141	0.000623	CcSEcCtD
Dantrolene—Pain—Losartan—type 2 diabetes mellitus	0.000141	0.000623	CcSEcCtD
Dantrolene—Rash—Gliclazide—type 2 diabetes mellitus	0.00014	0.000618	CcSEcCtD
Dantrolene—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00014	0.000617	CcSEcCtD
Dantrolene—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000139	0.000616	CcSEcCtD
Dantrolene—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000139	0.000615	CcSEcCtD
Dantrolene—Headache—Gliclazide—type 2 diabetes mellitus	0.000139	0.000614	CcSEcCtD
Dantrolene—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000138	0.000612	CcSEcCtD
Dantrolene—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000138	0.000612	CcSEcCtD
Dantrolene—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000138	0.000611	CcSEcCtD
Dantrolene—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000138	0.000609	CcSEcCtD
Dantrolene—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000138	0.000609	CcSEcCtD
Dantrolene—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000136	0.000604	CcSEcCtD
Dantrolene—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000136	0.0006	CcSEcCtD
Dantrolene—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000135	0.000595	CcSEcCtD
Dantrolene—Dizziness—Valsartan—type 2 diabetes mellitus	0.000135	0.000595	CcSEcCtD
Dantrolene—Anorexia—Ramipril—type 2 diabetes mellitus	0.000135	0.000595	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000134	0.00113	CbGpPWpGaD
Dantrolene—Dizziness—Orlistat—type 2 diabetes mellitus	0.000133	0.000588	CcSEcCtD
Dantrolene—Asthenia—Metformin—type 2 diabetes mellitus	0.000133	0.000588	CcSEcCtD
Dantrolene—Nausea—Gliclazide—type 2 diabetes mellitus	0.000132	0.000582	CcSEcCtD
Dantrolene—Pruritus—Metformin—type 2 diabetes mellitus	0.000131	0.00058	CcSEcCtD
Dantrolene—Urticaria—Losartan—type 2 diabetes mellitus	0.000131	0.000578	CcSEcCtD
Dantrolene—Body temperature increased—Losartan—type 2 diabetes mellitus	0.00013	0.000576	CcSEcCtD
Dantrolene—Abdominal pain—Losartan—type 2 diabetes mellitus	0.00013	0.000576	CcSEcCtD
Dantrolene—Vomiting—Valsartan—type 2 diabetes mellitus	0.000129	0.000572	CcSEcCtD
Dantrolene—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	0.000129	0.00109	CbGpPWpGaD
Dantrolene—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000129	0.00057	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000129	0.000569	CcSEcCtD
Dantrolene—Rash—Valsartan—type 2 diabetes mellitus	0.000128	0.000568	CcSEcCtD
Dantrolene—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000128	0.000567	CcSEcCtD
Dantrolene—Vomiting—Orlistat—type 2 diabetes mellitus	0.000128	0.000566	CcSEcCtD
Dantrolene—Insomnia—Ramipril—type 2 diabetes mellitus	0.000128	0.000565	CcSEcCtD
Dantrolene—Headache—Valsartan—type 2 diabetes mellitus	0.000127	0.000564	CcSEcCtD
Dantrolene—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000127	0.000561	CcSEcCtD
Dantrolene—Rash—Orlistat—type 2 diabetes mellitus	0.000127	0.000561	CcSEcCtD
Dantrolene—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000127	0.00056	CcSEcCtD
Dantrolene—Headache—Orlistat—type 2 diabetes mellitus	0.000126	0.000557	CcSEcCtD
Dantrolene—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000125	0.000555	CcSEcCtD
Dantrolene—Somnolence—Ramipril—type 2 diabetes mellitus	0.000125	0.000555	CcSEcCtD
Dantrolene—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000124	0.00055	CcSEcCtD
Dantrolene—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000124	0.000547	CcSEcCtD
Dantrolene—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000123	0.000543	CcSEcCtD
Dantrolene—Dizziness—Metformin—type 2 diabetes mellitus	0.000123	0.000542	CcSEcCtD
Dantrolene—Fatigue—Ramipril—type 2 diabetes mellitus	0.000122	0.000538	CcSEcCtD
Dantrolene—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000121	0.000536	CcSEcCtD
Dantrolene—Nausea—Valsartan—type 2 diabetes mellitus	0.000121	0.000535	CcSEcCtD
Dantrolene—Constipation—Ramipril—type 2 diabetes mellitus	0.000121	0.000534	CcSEcCtD
Dantrolene—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00012	0.000529	CcSEcCtD
Dantrolene—Nausea—Orlistat—type 2 diabetes mellitus	0.000119	0.000528	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	0.000118	0.000997	CbGpPWpGaD
Dantrolene—Asthenia—Losartan—type 2 diabetes mellitus	0.000118	0.000522	CcSEcCtD
Dantrolene—Vomiting—Metformin—type 2 diabetes mellitus	0.000118	0.000521	CcSEcCtD
Dantrolene—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	0.000117	0.000986	CbGpPWpGaD
Dantrolene—Rash—Metformin—type 2 diabetes mellitus	0.000117	0.000517	CcSEcCtD
Dantrolene—Dermatitis—Metformin—type 2 diabetes mellitus	0.000117	0.000516	CcSEcCtD
Dantrolene—Pruritus—Losartan—type 2 diabetes mellitus	0.000116	0.000515	CcSEcCtD
Dantrolene—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000116	0.000514	CcSEcCtD
Dantrolene—Headache—Metformin—type 2 diabetes mellitus	0.000116	0.000514	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	0.000116	0.000976	CbGpPWpGaD
Dantrolene—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000116	0.000512	CcSEcCtD
Dantrolene—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000115	0.000511	CcSEcCtD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	0.000114	0.000964	CbGpPWpGaD
Dantrolene—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000113	0.000498	CcSEcCtD
Dantrolene—Urticaria—Ramipril—type 2 diabetes mellitus	0.000112	0.000496	CcSEcCtD
Dantrolene—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000112	0.000494	CcSEcCtD
Dantrolene—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000112	0.000494	CcSEcCtD
Dantrolene—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000111	0.000492	CcSEcCtD
Dantrolene—Rash—Irbesartan—type 2 diabetes mellitus	0.00011	0.000488	CcSEcCtD
Dantrolene—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00011	0.000487	CcSEcCtD
Dantrolene—Nausea—Metformin—type 2 diabetes mellitus	0.00011	0.000487	CcSEcCtD
Dantrolene—Headache—Irbesartan—type 2 diabetes mellitus	0.00011	0.000485	CcSEcCtD
Dantrolene—Dizziness—Losartan—type 2 diabetes mellitus	0.000109	0.000481	CcSEcCtD
Dantrolene—RYR1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000106	0.000893	CbGpPWpGaD
Dantrolene—Vomiting—Losartan—type 2 diabetes mellitus	0.000105	0.000463	CcSEcCtD
Dantrolene—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000104	0.00046	CcSEcCtD
Dantrolene—Nausea—Irbesartan—type 2 diabetes mellitus	0.000104	0.00046	CcSEcCtD
Dantrolene—Rash—Losartan—type 2 diabetes mellitus	0.000104	0.000459	CcSEcCtD
Dantrolene—Dermatitis—Losartan—type 2 diabetes mellitus	0.000104	0.000459	CcSEcCtD
Dantrolene—Headache—Losartan—type 2 diabetes mellitus	0.000103	0.000456	CcSEcCtD
Dantrolene—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	0.000102	0.000856	CbGpPWpGaD
Dantrolene—Asthenia—Ramipril—type 2 diabetes mellitus	0.000101	0.000448	CcSEcCtD
Dantrolene—Pruritus—Ramipril—type 2 diabetes mellitus	9.98e-05	0.000442	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	9.91e-05	0.000834	CbGpPWpGaD
Dantrolene—Nausea—Losartan—type 2 diabetes mellitus	9.78e-05	0.000433	CcSEcCtD
Dantrolene—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000427	CcSEcCtD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	9.57e-05	0.000806	CbGpPWpGaD
Dantrolene—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	9.5e-05	0.0008	CbGpPWpGaD
Dantrolene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	9.46e-05	0.000797	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	9.44e-05	0.000795	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	9.4e-05	0.000792	CbGpPWpGaD
Dantrolene—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	9.34e-05	0.000787	CbGpPWpGaD
Dantrolene—Dizziness—Ramipril—type 2 diabetes mellitus	9.33e-05	0.000413	CcSEcCtD
Dantrolene—Vomiting—Ramipril—type 2 diabetes mellitus	8.97e-05	0.000397	CcSEcCtD
Dantrolene—Rash—Ramipril—type 2 diabetes mellitus	8.9e-05	0.000394	CcSEcCtD
Dantrolene—Dermatitis—Ramipril—type 2 diabetes mellitus	8.89e-05	0.000393	CcSEcCtD
Dantrolene—Headache—Ramipril—type 2 diabetes mellitus	8.84e-05	0.000391	CcSEcCtD
Dantrolene—Nausea—Ramipril—type 2 diabetes mellitus	8.38e-05	0.000371	CcSEcCtD
Dantrolene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	8.19e-05	0.00069	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	7.76e-05	0.000653	CbGpPWpGaD
Dantrolene—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	7.67e-05	0.000646	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	5.15e-05	0.000434	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	4.99e-05	0.00042	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	4.92e-05	0.000415	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	4.12e-05	0.000347	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	4.07e-05	0.000343	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	4.06e-05	0.000342	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	4.02e-05	0.000338	CbGpPWpGaD
Dantrolene—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	3.12e-05	0.000263	CbGpPWpGaD
Dantrolene—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	3.08e-05	0.000259	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	2.38e-05	0.000201	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	2.08e-05	0.000175	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	2.08e-05	0.000175	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.97e-05	0.000166	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.97e-05	0.000166	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.88e-05	0.000159	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.74e-05	0.000146	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.74e-05	0.000146	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.68e-05	0.000141	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.68e-05	0.000141	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.68e-05	0.000141	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.68e-05	0.000141	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.68e-05	0.000141	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.63e-05	0.000137	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.53e-05	0.000129	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.53e-05	0.000129	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.5e-05	0.000126	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.43e-05	0.00012	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.43e-05	0.00012	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.43e-05	0.00012	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.37e-05	0.000115	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.37e-05	0.000115	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.32e-05	0.000111	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.32e-05	0.000111	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.29e-05	0.000109	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.27e-05	0.000107	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.27e-05	0.000107	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.27e-05	0.000107	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	1.2e-05	0.000101	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	1.12e-05	9.43e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	1.08e-05	9.11e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	1.08e-05	9.11e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	1.08e-05	9.11e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	1.08e-05	9.11e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	1.04e-05	8.73e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	9.64e-06	8.12e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	9e-06	7.58e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	8.82e-06	7.42e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	8.82e-06	7.42e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	8.65e-06	7.28e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	8.59e-06	7.24e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	8.59e-06	7.24e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	8.59e-06	7.24e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	8.54e-06	7.19e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	8.39e-06	7.06e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	8.29e-06	6.98e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	7.71e-06	6.49e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	7.71e-06	6.49e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	7.71e-06	6.49e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	7.56e-06	6.37e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	7.5e-06	6.31e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	7.34e-06	6.18e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	7.05e-06	5.94e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	6.97e-06	5.87e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	6.97e-06	5.87e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	6.68e-06	5.63e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	6.68e-06	5.63e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.76e-06	4.85e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	5.76e-06	4.85e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	5.73e-06	4.83e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	5.66e-06	4.76e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	5.49e-06	4.62e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	5.34e-06	4.5e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	5.24e-06	4.42e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	5.13e-06	4.32e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	5.11e-06	4.31e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.98e-06	4.2e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.92e-06	4.14e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	4.72e-06	3.98e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	4.63e-06	3.9e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	4.48e-06	3.78e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	4.41e-06	3.71e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	4.39e-06	3.7e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	4.34e-06	3.66e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.83e-06	3.22e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.75e-06	3.16e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	3.44e-06	2.9e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	3.29e-06	2.77e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	3.29e-06	2.77e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	3.01e-06	2.54e-05	CbGpPWpGaD
Dantrolene—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.51e-06	1.27e-05	CbGpPWpGaD
